Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines
DNA vaccines showed great promise in preclinical models of infectious and malignant diseases, but their potency was insufficient in clinical trials and is needed to be improved. In this study, we tested systemic administration of two conventional adjuvants, synthetic oligodeoxynucleotide carrying im...
Main Authors: | Michal Šmahel, Ingrid Poláková, Eva Sobotková, Eva Vajdová |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/176759 |
Similar Items
-
CpG Oligodeoxynucleotides as a Future Vaccine for Allergic Diseases
by: Kunio Sano, et al.
Published: (2005-01-01) -
Incorporation of CpG Oligodeoxynucleotides into α2-Macroglobulin: Development of a Novel Vaccine Adjuvant Delivery Mechanism
by: Anderson, Ryan Berger
Published: (2007) -
The Preparation and Effect of Porcine Cytokine IL-6 and CpG Oligodeoxynucleotides Adjuvant for Actinobacillus pleuropneumoniae DNA Vaccine
by: Chien-Ju Yeh, et al.
Published: (2007) -
Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
by: Seiki Shirai, et al.
Published: (2020-01-01) -
A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice
by: Pengcheng Yu, et al.
Published: (2018-11-01)